Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Physical Therapy (USPH) Capital Expenditures (2016 - 2025)

U S Physical Therapy's Capital Expenditures history spans 12 years, with the latest figure at $2.2 million for Q4 2023.

  • For Q4 2023, Capital Expenditures rose 131.73% year-over-year to $2.2 million; the TTM value through Dec 2023 reached $9.3 million, up 12.68%, while the annual FY2025 figure was $14.1 million, 53.18% up from the prior year.
  • Capital Expenditures for Q4 2023 was $2.2 million at U S Physical Therapy, down from $2.6 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $2.8 million in Q4 2019 and bottomed at $866000.0 in Q3 2020.
  • The 5-year median for Capital Expenditures is $2.3 million (2019), against an average of $2.2 million.
  • The largest annual shift saw Capital Expenditures plummeted 66.07% in 2020 before it skyrocketed 211.2% in 2021.
  • A 5-year view of Capital Expenditures shows it stood at $2.8 million in 2019, then decreased by 22.31% to $2.1 million in 2020, then increased by 2.8% to $2.2 million in 2021, then crashed by 56.55% to $958000.0 in 2022, then surged by 131.73% to $2.2 million in 2023.
  • Per Business Quant, the three most recent readings for USPH's Capital Expenditures are $2.2 million (Q4 2023), $2.6 million (Q3 2023), and $2.5 million (Q2 2023).